Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin

• Published in: Canadian journal of veterinary research 1997-07, Vol.61 (3), p.187-192
• Main Authors: Morck, D.W, Merrill, J.K, Gard, M.S, Olson, M.E, Nation, P.N
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents; body temperature; calves; Cattle; Cattle Diseases - pathology; Chromatography, High Pressure Liquid - methods; Chromatography, High Pressure Liquid - veterinary; Dose-Response Relationship, Drug; experimental infections; Hemorrhage - pathology; Hemorrhage - veterinary; histopathology; Lung - chemistry; Lung - microbiology; Lung - pathology; lungs; macrolide antibiotics; Macrolides; Male; Mannheimia haemolytica; Mannheimia haemolytica - isolation & purification; Pasteurellosis, Pneumonic - drug therapy; Pasteurellosis, Pneumonic - etiology; Pasteurellosis, Pneumonic - pathology; pharmacokinetics; pharmacology; Random Allocation; subcutaneous injection; Time Factors; Tylosin - analogs & derivatives; Tylosin - analysis; Tylosin - blood; Tylosin - therapeutic use; young animals
• ISSN: 0830-9000

Twenty four (24) healthy male Holstein calves (< 70 kg) were each experimentally infected by intrabronchial inoculation of 4.0 x 10(9) viable cells of Pasteurella haemolytica-AI (B122) at Time = 0 h. At 1 h following inoculation animals received either: 1) Sham treatment with sterile 0.85% saline SC (n = 12); or 2) a single injection of 10 mg tilmicosin per kg body weight (n = 12). Calves that were non-infected and tilmicosin-treated were also included for determining tilmicosin concentrations in serum and lung tissue at 1, 2, 4, 6, 8, 24, 48, and 72 h (n = 3-per time). In the infected calves, response to therapy was monitored clinically. Serum samples were collected for determination of tilmicosin concentrations using HPLC. Any animal becoming seriously ill was humanely killed. Complete necropsy examinations were performed on all animals and included gross pathologic changes, bacteriologic analysis, histopathology, and determination of pulmonary concentrations of tilmicosin. Tilmicosin treated animals responded significantly better to therapy than saline-treated control calves. Clinical assessment of calves during the study indicated that tilmicosin-treated calves had significantly improved by T = 8 h compared to satine-treated animals (P < 0.05). At necropsy tilmicosin-treated calves had significantly less severe gross and histological lesions (P < 0.05) of the pulmonary tissue. Of the 12 saline-treated calves, 92% (11/12) had Pasteurella haemolytica-A1 in lung tissue, while of the tilmicosin-treated calves 0% (0/12) cultured positive for P. haemolytica. Mean (+/- standard error) serum tilmicosin concentrations in infected calves peaked at 1 h post-injection (1.10 +/- 0.06 micrograms/mL) and rapidly decreased to 0.20 +/- 0.03 microgram/mL, well below the MIC of 0.50 microgram/mL for P. haemolytica-A1 (B122), by 12 h. These serum concentrations were very similar to serum concentrations of tilmicosin in non-infected tilmicosin-treated calves. Lung tissue concentrations of the antibiotic were comparatively high, even at 72 h post-infection (6.50 +/- 0.75 ppm). Lung tissue concentrations at 72 h were significantly higher in experimentally infected calves than in non-infected tilmicosin-treated animals (P < 0.05). These data demonstrate that tilmicosin was effective in treating experimentally-induced pneumonic pasteurellosis as determined by alleviation of clinical signs, pathological findings at post mortem, and presence of viable bacteria from the lung. Con